Your browser doesn't support javascript.
loading
Inhibition of Parkinson's disease-related LRRK2 by type I and type II kinase inhibitors: Activity and structures.
Sanz Murillo, Marta; Villagran Suarez, Amalia; Dederer, Verena; Chatterjee, Deep; Alegrio Louro, Jaime; Knapp, Stefan; Mathea, Sebastian; Leschziner, Andres E.
Afiliación
  • Sanz Murillo M; Department of Cellular and Molecular Medicine, School of Medicine, University of California San Diego, La Jolla, CA 92093, USA.
  • Villagran Suarez A; Aligning Science Across Parkinson's (ASAP) Collaborative Researcg Network, Chevy Chase, MD 20815, USA..
  • Dederer V; Department of Cellular and Molecular Medicine, School of Medicine, University of California San Diego, La Jolla, CA 92093, USA.
  • Chatterjee D; Aligning Science Across Parkinson's (ASAP) Collaborative Researcg Network, Chevy Chase, MD 20815, USA..
  • Alegrio Louro J; Aligning Science Across Parkinson's (ASAP) Collaborative Researcg Network, Chevy Chase, MD 20815, USA..
  • Knapp S; Institute of Pharmaceutical Chemistry, Goethe-Universität, Frankfurt 60438, Germany.
  • Mathea S; Structural Genomics Consortium (SGC), Buchmann Institute for Life Sciences, Goethe-Universität, Frankfurt 60438, Germany.
  • Leschziner AE; Aligning Science Across Parkinson's (ASAP) Collaborative Researcg Network, Chevy Chase, MD 20815, USA..
Sci Adv ; 9(48): eadk6191, 2023 12.
Article en En | MEDLINE | ID: mdl-38039358

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson Límite: Humans Idioma: En Revista: Sci Adv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson Límite: Humans Idioma: En Revista: Sci Adv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos